Articles From: Cerus Corporation Reports Second Quarter 2014 Results to CEVA, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call


Cerus Corporation (NASDAQ:CERS) today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Cerus Corporation Reports Second Quarter 2014 Results investment picks
Cerus Corporation (NASDAQ: CERS) announced today that it has submitted the third and final module for its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA), for review of the INTERCEPT Blood System for platelets.
Sign-up for Cerus Submits Final Module in Premarket Approval (PMA) Application Process for INTERCEPT Platelets investment picks
Cerus Corporation (NASDAQ:CERS) announced today that it has submitted a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for platelets available under an Expanded Access Investigational Device Exemption (IDE) to regions in the United States with outbreaks of Chikungunya and dengue.
Sign-up for Cerus Submits IDE Supplement to Make INTERCEPT Platelets Available Pre-Approval in U.S. Areas at Risk from Outbreaks of Chikungunya and Dengue investment picks
Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, vice president and chief financial officer, is scheduled to present a corporate update at the Baird 2014 Health Care Conference at 7:55 AM ET on Wednesday, September 3, 2014.
Sign-up for Cerus to Present at the Baird 2014 Health Care Conference on September 3, 2014 investment picks
Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Morgan Stanley 2014 Global Health Care Conference at 10:55 AM ET on Wednesday, September 10, 2014.
Sign-up for Cerus to Present at the Morgan Stanley 2014 Global Health Care Conference on September 10, 2014 investment picks
Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Wedbush 2014 Life Sciences Management Access Conference at 8:35 AM ET on Tuesday, August 12, 2014.
Sign-up for Cerus to Present at the Wedbush 2014 Life Sciences Management Access Conference on August 12, 2014 investment picks
Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, July 31 2014, after the close of the stock market.
Sign-up for Cerus to Release Second Quarter 2014 Results on July 31, 2014 investment picks
Cervus clarifies ICFR & DC&P conclusions - no impact on previously filed financial results Canada NewsWire Symbol: CVL (TSX) TORONTO , Oct.
Sign-up for Cervus clarifies ICFR & DC&P conclusions - no impact on previously filed financial results investment picks
Cervus Equipment Corp.
Sign-up for Cervus Equipment Corp. Announces Second Quarter 2014 Results investment picks
Cervus Equipment Corporation announces Definitive Agreement to acquire Evergreen Equipment Ltd.
Sign-up for Cervus Equipment Corporation announces Definitive Agreement to acquire Evergreen Equipment Ltd. investment picks
Cervus Equipment Corporation announces dividend Canada NewsWire Symbol: CVL (TSX) CALGARY , Sept.
Sign-up for Cervus Equipment Corporation announces dividend investment picks
Cervus Equipment Corporation Completes Acquisition of Peterbilt of Ontario Inc. Canada NewsWire Symbol: CVL (TSX) CALGARY , Aug.
Sign-up for Cervus Equipment Corporation Completes Acquisition of Peterbilt of Ontario Inc. investment picks
CES Group LLC, a subsidiary of Nortek, Inc. (NASDAQ: NTK), and a leading manufacturer of innovative custom and engineered solutions for heating, ventilating and cooling, today announced their worldwide alliance with CoolIT Systems Inc., the global expert in Direct Contact Liquid Cooling (DCLC™) technologies with the signing of a global OEM and Distribution Agreement.
Sign-up for CES Group Announces Strategic OEM and Distribution Agreement with CoolIT Systems investment picks
RANCHO CORDOVA, Calif., July 8, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL) , an autologous cell-based regenerative medicine company, announced today that it recently participated in a pre-submission IDE (Investigational Device Exemption) teleconference with the Food and Drug Administration's ("FDA") Center for Biologics Evaluation and Research to discuss the Company's proposed pivotal clinical trial design for the treatment of Critical Limb Ischemia ("CLI") using its CLIRST (Critical Limb Ischemia Rapid Stem cell Therapy) treatment protocol delivered via the Company's proprietary SURGWERKS-CLI kit.
Sign-up for CESCA Management Provides Regulatory Update on Its Proposed U.S. Pivotal Critical Limb Ischemia Clinical Trial investment picks
RANCHO CORDOVA, Calif., Aug.
Sign-up for Cesca Therapeutics Advocates Benefits of Cell Therapy to the Centers for Medicare and Medicaid Services investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Reschedules Fourth Quarter and Full Year Earnings Release investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics to Announce Fourth Quarter and Fiscal 2014 Year End Results on September 25, 2014 investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics to Present at Aegis Healthcare & Technology Conference investment picks
RANCHO CORDOVA, Calif., Oct.
Sign-up for Cesca Therapeutics to Present at Stem Cell Meeting on the Mesa investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics to Present at the Rodman & Renshaw(R) 16th Annual Global Investment Conference investment picks
Cessna Aircraft Company, a subsidiary of Textron Aviation Inc, a Textron Inc. (NYSE: TXT) company, announced today it received type certification from the U.S. Federal Aviation Administration for the Cessna Citation CJ3+. Certification, awarded Thursday, comes less than six months after the company introduced the new model in March.
Sign-up for Cessna Citation CJ3+ Gains FAA Certification investment picks
Antoniades to Assume Role of Chair of FSI Board of Directors in 2015 SAN DIEGO , Aug.
Sign-up for Cetera Financial Group Announces Appointment of Adam Antoniades as Vice Chair of the Board of Directors of the Financial Services Institute investment picks
2014/9/11
LOS ANGELES , Sept.
Sign-up for Cetera Financial Group Announces Grant as Part of its Caring Cetera Initiative investment picks
2014/8/12
Network Structure Enables Enhanced Tools and Resources for Member Broker-Dealer Firms and Advisors, While Reinforcing Unique Brands and Cultures Sets New Industry Standard for Balance Between Scale and Personalization LOS ANGELES , Aug.
Sign-up for Cetera Financial Group Announces New Strategic Framework investment picks
2014/8/13
Conference Features Top Industry Experts and Peer-to-Peer Instruction to Enhance Advisor Education at All Levels of Professional Achievement LOS ANGELES , Aug.
Sign-up for Cetera Financial Group Kicks Off Annual Wealth Management University Event with Nearly 200 Attendees investment picks
- Continued diversification of customer base with ten out of eleven agreements signed in quarter targeting non-baseband applications - Company bought back $10.1 million in CEVA shares during the quarter MOUNTAIN VIEW, Calif.
Sign-up for CEVA, Inc. Announces Second Quarter 2014 Financial Results investment picks
MOUNTAIN VIEW, Calif.
Sign-up for CEVA, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Cerus Corporation Reports Second Quarter 2014 Results to CEVA, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices